Investment
Features
FeesSafety
Academy
More
Pluang+

Compare AbCellera Biologics Inc (ABCL) vs Paychex, Inc. (PAYX) Price & Performance

AbCellera Biologics IncTrade
Paychex, Inc.Trade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Paychex, Inc. — how do they compare? AbCellera Biologics Inc trades at $9.13 (market cap $2.99B), while Paychex, Inc. trades at $120.92 (market cap $43.14B). The key difference: Paychex, Inc. is far larger — about 14.4× AbCellera Biologics Inc's market cap, and Paychex, Inc. pays a 3.92% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.

ABCLPAYX
Market Cap
$2.99B$43.14B
Sector
HealthIndustrials
52-Week High
$9.76$140.81
52-Week Low
$2.78$85.57
Enterprise Value
$2.58B$46.63B
Dividend Yield
3.92%

Returns comparison

Trailing returns across standard periods

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Read more on ABCL

About Paychex, Inc.

Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.

Read more on PAYX